Compare · OLPX vs UG
OLPX vs UG
Side-by-side comparison of Olaplex Holdings Inc. (OLPX) and United-Guardian Inc. (UG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OLPX and UG operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- OLPX is the larger of the two at $13.11B, about 161.2x UG ($81.3M).
- OLPX has been more active in the news (2 items in the past 4 weeks vs 1 for UG).
- OLPX has more recent analyst coverage (25 ratings vs 0 for UG).
- Company
- Olaplex Holdings Inc.
- United-Guardian Inc.
- Price
- $2.04+0.00%
- $6.71+6.17%
- Market cap
- $13.11B
- $81.3M
- 1M return
- +51.87%
- -
- 1Y return
- +57.14%
- -
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 1
- Recent ratings
- 25
- 0
United-Guardian Inc.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. The company's medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. The company's industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. It also conducts research and development primarily related to the development of cosmetic ingredients. The company markets its products through marketing partners, distributors, and wholesalers. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Latest OLPX
- SEC Form PREM14C filed by Olaplex Holdings Inc.
- SEC Form 4 filed by Duffy John C
- Olaplex Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure
- OLAPLEX, a Leading, Science-Led Prestige Hair Care Brand, to be Acquired by Henkel for $1.4 Billion
- Chief People Officer Fox Trisha L sold $32,030 worth of shares (25,421 units at $1.26), decreasing direct ownership by 2% to 1,080,363 units (SEC Form 4)
- General Counsel Duffy John C sold $44,052 worth of shares (34,962 units at $1.26), decreasing direct ownership by 3% to 982,855 units (SEC Form 4)
- COO and CFO Dunleavy Catherine sold $118,199 worth of shares (93,809 units at $1.26), decreasing direct ownership by 3% to 3,026,885 units (SEC Form 4)
- Chief Executive Officer Baldwin Amanda sold $528,649 worth of shares (451,837 units at $1.17), decreasing direct ownership by 5% to 9,129,515 units (SEC Form 4)
- SEC Form 144 filed by Olaplex Holdings Inc.
- SEC Form 144 filed by Olaplex Holdings Inc.
Latest UG
- SEC Form DEF 14A filed by United-Guardian Inc.
- SEC Form 10-K filed by United-Guardian Inc.
- United-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- United-Guardian Reports 2025 Financial Results
- United-Guardian Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- United-Guardian Declares Cash Dividend
- Director Globus Kenneth H gifted 7,480 shares (SEC Form 4)
- SEC Form 10-Q filed by United-Guardian Inc.
- United-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- United-Guardian Reports Third Quarter Earnings